Treace Medical Concepts (TMCI) Payables (2020 - 2026)

Treace Medical Concepts has reported Payables for 7 years, with the latest figure at $15.3 million in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 15.41% year-over-year to $15.3 million; the trailing twelve-month figure through Mar 2026 stood at $15.3 million (up 15.41% YoY), and the FY2025 full-year result was $8.5 million, down 19.49% from the prior year.
• Payables for Q1 2026 stood at $15.3 million, up from $8.5 million in the prior quarter.
• The five-year high for Payables was $21.1 million in Q1 2024, with the low at $3.1 million in Q2 2022.
• Historically, Payables has averaged $11.8 million across 5 years, with a median of $10.5 million in 2024.
• Annual changes were most pronounced in 2024 — Payables jumped 316.65% — and 2025, when it sank 37.26%.
• Treace Medical Concepts' Payables stood at $8.7 million in 2022, then soared by 36.54% to $11.8 million in 2023, then slipped by 11.09% to $10.5 million in 2024, then fell by 19.49% to $8.5 million in 2025, then surged by 80.77% to $15.3 million in 2026.
• The last three Payables figures came in at $15.3 million (Q1 2026), $8.5 million (Q4 2025), and $17.9 million (Q3 2025), per Business Quant data.